- Category
- Small (2024-25)
- Udyam number
- UDYAM-PB-20-0010715

About Quixotic Pharma Private Limited
Data last updated:
Quixotic Pharma Private Limited is a private limited company based in Mohali, Punjab, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 29 November 2002 and has been in existence for over 24 years.
The company is registered with the Registrar of Companies (ROC), Chandigarh, under CIN U24232PB2002PTC025609. Its GSTIN is 03AAACQ0959P1Z5 (Punjab).
The company has an authorised share capital of ₹20 Lakh and a paid-up capital of ₹7.44 Lakh. It is led by directors including Sudhakar and Sanjay Dhir.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 569 Industrial Areaphase IX Mohali, Punjab, India – 160062.
As per the financials filed for FY 2025, the company reported a revenue of ₹27.58 Cr, a decline of 8% compared to the previous year. For the same year it recorded a net profit of ₹19.16 Lakh (net margin 0.7%) and EBITDA of ₹83.88 Lakh (EBITDA margin 3%). Revenue has declined at a compounded annual rate (CAGR) of 14% over three years.
The company has about 2 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: Eucee. Court records list 11 cases involving the company, including 1 filed by the company and 10 filed against it; 8 cases are pending.
Quixotic Pharma Private Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-PB-20-0010715). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website eucee.in.
Company details
Recognitions & Rankings of Quixotic Pharma
Contact details
Quixotic Pharma Private Limited's registered office is in Mohali, Punjab. Its website is eucee.in. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered Address569 Industrial Areaphase IX Mohali, Punjab, India – 160062
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Quixotic Pharma Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activities of Quixotic Pharma are manufacturing and trade. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products and wholesale trading. 2 activity segments are registered with the MCA.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products | |
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Quixotic Pharma Private Limited, buy the company report.
Financials of Quixotic Pharma Private Limited
FY 2025 filings availableQuixotic Pharma Private Limited reported revenue of ₹27.58 Cr (down 8% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has declined at a compounded annual rate (CAGR) of 14% over three years, including a 8% fall in the latest year. EBITDA fell 8% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹83.88 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹19.16 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 3% | ||||
| Net Profit Margin | 0.7% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Quixotic Pharma Private Limited, buy the company report.
Board of directors of Quixotic Pharma Private Limited
Quixotic Pharma has 6 current directors and 7 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Sudhakar | Director | 11 Sep 2023 | 3 Years 1 Months | Current |
| Sanjay Dhir | Director | 01 Feb 2018 | 8 Years 9 Months | Current |
| Rajesh Biswanath Shrivastava Also directs: Ultra Chiron Pharmaceuticals Pvt Ltd | Director | 13 Aug 2019 | 7 Years 2 Months | Current |
| Sanjeev Kumar Also directs: Ultra Chiron Pharmaceuticals Pvt Ltd, Zenlabs Ethica Limited, Oasis Pharma and Phytomolecules Private Limited and 3 more | Director | 29 Nov 2002 | 23 Years 11 Months | Current |
| Hitesh Popatlal Oswal | Director | 01 Feb 2018 | 8 Years 9 Months | Current |
| Ashok Kumar Mishra Also directs: Ultra Chiron Pharmaceuticals Pvt Ltd | Director | 06 Mar 2025 | 1 Years 7 Months | Current |
Peer comparison
Quixotic Pharma Private Limited is compared with the 6 companies closest to it by revenue in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Anthea Pharma Private Limited | ₹27.78 Cr (FY 2025) | 516.0% | Hyderabad, Telangana, India | |||
| Sain Medicaments Private Limited | ₹27.64 Cr (FY 2025) | 4.0% | Telangana, India | |||
| Jips Pharmaceuticals Private Limited | ₹27.63 Cr (FY 2023) | 19.0% | Chandigarh, India | |||
| Quixotic Pharma Private Limitedthis company | ₹27.58 Cr (FY 2025) | ₹19.16 Lakh | 0.7% | -8.0% | 2 | Mohali, Punjab, India |
| Augxen Pharma Private Limited | ₹27.52 Cr (FY 2025) | 134.0% | Bharuch, Gujarat, India | |||
| Cirex Pharmaceuticals Private Limited | ₹27.51 Cr (FY 2025) | 487.0% | Hyderabad, Telangana, India | |||
| Acme Diet Care Private Limited | ₹27.35 Cr (FY 2025) | 17.0% | Ahmedabad, Gujarat, India |
To see the full peer comparison of Quixotic Pharma Private Limited, buy the company report.
Auditor
Quixotic Pharma Private Limited is audited by N KUMAR CHHABRA & CO for the financial year 2022.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| N KUMAR CHHABRA & CO | FY 2022 | 000837N |
Shareholding
The shareholding of Quixotic Pharma Private Limited is on record for 5 financial years, the latest being FY 2022, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Quixotic Pharma Private Limited, buy the company report.
Legal cases
Quixotic Pharma Private Limited has 11 court cases on record: 1 filed by Quixotic Pharma, 10 filed against it. 8 cases are pending and 3 are disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 11 | 10 | 8 |
Cases on record (5 of 11)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, SAS Nagar, Punjab | Civil suit | Filed by the company against Cadila Pharmaceuticals Limited | Pending |
| District court, Chandigarh | Court case (TRADE MARK) | Filed against the company by Ms Raptakos Brett and Company Ltd | Disposed |
| District court, Ramanathapuram, Tamil Nadu | Criminal case | Filed against the company by an individual | Pending |
| District court, Chandigarh | Court case (CS CJ) | Filed against the company by an individual | Pending |
| District court, Tiruppur, Tamil Nadu | Court case (PRC) | Filed against the company by an individual | Pending |
To see the full case history of Quixotic Pharma Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
Quixotic Pharma Private Limited has 7 MSME Form 1 returns on record between 2021 and 2023, listing 1,269 overdue payments to 30 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (5 of 30)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| Jasco Paper Products | |||
| an individual supplier | |||
| Akhil Healthcare Private Limited | |||
| an individual supplier | |||
| an individual supplier |
To see the full MSME payment records of Quixotic Pharma Private Limited, buy the company report.
Individuals and sole proprietors among the suppliers are not named.
Employees & EPFO
Quixotic Pharma Private Limited has a workforce of 2 employees on its EPFO records as of Apr 06, 2024, across 1 active EPFO establishment.
GST
Quixotic Pharma has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 03AAACQ0959P1Z5 | Punjab | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Quixotic Pharma Private Limited, buy the company report.
Recent activity
Quixotic Pharma Private Limited has 13 board changes on record since 2002: 6 appointments and 7 cessations. The latest: Ashok Kumar Mishra ceased to be Additional Director on 29 Sep 2025.
4 earlier events are in the company report.
Frequently asked questions
Quixotic Pharma is an active private limited company based in Mohali, Punjab, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 29 November 2002 (24+ years old) and is registered under CIN U24232PB2002PTC025609.
Quixotic Pharma has 6 current directors:
- Sudhakar - Director
- Sanjay Dhir - Director
- Rajesh Biswanath Shrivastava - Director
- Sanjeev Kumar - Director
- Hitesh Popatlal Oswal - Director
- Ashok Kumar Mishra - Director
The latest financial statements of Quixotic Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Quixotic Pharma is 03AAACQ0959P1Z5, registered in Punjab.
The CIN (Corporate Identification Number) of Quixotic Pharma is U24232PB2002PTC025609. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Quixotic Pharma has 11 court cases on record: 1 filed by the company and 10 filed against it. 8 are pending.
Quixotic Pharma was incorporated on 29 November 2002, making it 24+ years old. It is registered with the Registrar of Companies, Chandigarh.
The peers of Quixotic Pharma by revenue are Anthea Pharma Private Limited, Sain Medicaments Private Limited, Jips Pharmaceuticals Private Limited, Augxen Pharma Private Limited, Cirex Pharmaceuticals Private Limited and 1 more, all in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Ashok Kumar Mishra ceased to be Additional Director on 29 Sep 2025. Ashok Kumar Mishra was appointed as Director on 06 Mar 2025. Sudhakar ceased to be Additional Director on 29 Sep 2023. Quixotic Pharma has 13 board changes on record in total.
Yes, Quixotic Pharma is registered as a small enterprise under Udyam registration (number: UDYAM-PB-20-0010715).
Quixotic Pharma has 7 MSME Form 1 returns on record between 2021 and 2023, listing 1,269 overdue payments to 30 micro and small suppliers. The latest return was filed on 26 Apr 2023.
Quixotic Pharma can be reached through the website eucee.in. Its registered office is in Mohali, Punjab, India.

